|
Video: What is a Stock Split?
|
|
Allarity Therapeutics is a biopharmaceutical company developing therapeutic candidates together with its proprietary DRP® companion diagnostics. Co.'s lead therapeutic candidate, dovitinib, is a selective inhibitor of several classes of tyrosine kinases, including fibroblast growth factor receptors and vascular endothelial growth factor receptor for the treatment of third line renal cell carcinoma in patients. Co.'s second therapeutic candidate is stenoparib and Co. is developing this candidate for the treatment of ovarian cancer. Co.'s third candidate is IXEMPRA® (ixabepilone), a selective microtubule inhibitor, which has been shown to interfere with cancer cell division. According to our ALLR split history records, Allarity Therapeutics has had 4 splits. | |
|
Allarity Therapeutics (ALLR) has 4 splits in our ALLR split history database. The first split for ALLR took place on March 15, 2000. This was a 2 for 1
split, meaning for each share of ALLR owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. ALLR's second split took place on March 27, 2023. This was a 1 for 35 reverse split, meaning for each 35 shares of ALLR owned pre-split, the shareholder now owned 1 share. For example, a 2000 share position pre-split, became a 57.1428571428571 share position following the split. ALLR's third split took place on June 29, 2023. This was a 1 for 40 reverse split, meaning for each 40 shares of ALLR owned pre-split, the shareholder now owned 1 share. For example, a 57.1428571428571 share position pre-split, became a 1.42857142857143 share position following the split. ALLR's 4th split took place on April 09, 2024. This was a 1 for 20 reverse split, meaning for each 20 shares of ALLR owned pre-split, the shareholder now owned 1 share. For example, a 1.42857142857143 share position pre-split, became a 0.0714285714285714 share position following the split.
When a company such as Allarity Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as Allarity Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ALLR split history from start to finish, an original position size of 1000 shares would have turned into 0.0714285714285714 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Allarity Therapeutics shares, starting with a $10,000 purchase of ALLR, presented on a split-history-adjusted basis factoring in the complete ALLR split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/22/2021 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$353,504.00 |
|
End price/share: |
$1.37 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-99.52% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.04 |
|
Years: |
2.34 |
|
|
|
Date |
Ratio |
03/15/2000 | 2 for 1
| 03/27/2023 | 1 for 35 | 06/29/2023 | 1 for 40 | 04/09/2024 | 1 for 20 |
|
|